Payali, Noradja .

HRN: 16 17 82  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/22/2022
CEFTRIAXONE 1G (VIAL)
07/22/2022
07/29/2022
IV
2g
OD
UTI
Waiting Final Action 
07/26/2022
CEFUROXIME 500MG (TAB)
07/26/2022
08/02/2022
PO
500mg
BID X 7 Days
UTI; G5P4 (4002) Pregnancy Uterine
Waiting Final Action 
07/26/2022
METRONIDAZOLE 500MG (TAB)
07/26/2022
08/02/2022
PO
500mg
TID X 7 Days
UTI; G5P4 (4002) Pregnancy Uterine
Waiting Final Action 
11/13/2022
AZITHROMYCIN 500MG TABLET (TAB)
11/13/2022
11/17/2022
TAB
500 Mg
OD
RAgt Positive COVID 19 Infection, Mild
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: